IGC IGC Pharma, Inc.
IGC Pharma, Inc. (IGC) is expected to report earnings on November 13, 2026, before the market open. The consensus earnings estimate is a loss of $0.02 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -0.4% since its last earnings release on August 14, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About IGC Pharma, Inc.
India Globalization Capital Inc is engaged in acquiring, incubating, financing and growing companies in multiple industries & locations. The Company trades iron ore & lease construction equipment in India; and operates iron ore plants in China.
Sector
Healthcare
Industry
Drug Manufacturers/Other